Freke R. Zuure
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Freke R. Zuure has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Udi Davidovich
Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands
4 shared publications - Maria Prins
Department of Infectious Diseases Research and Prevention, Public Health Service of Amsterdam, Amsterdam, the Netherlands
3 shared publications Anneke van Den Hoek
Public Health Service of Amsterdam Amsterdam The Netherlands
2 shared publications- Anouk T. Urbanus
Amsterdam Public Health Service, Cluster of Infectious Diseases
2 shared publications Christine J. Weegink
Center for Infection and Immunology Amsterdam (CINIMA) Academic Medical Center (University of Amsterdam) Amsterdam The Netherlands
2 shared publications- Gerjo Kok
Department of Work & Social Psychology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands
2 shared publications
Latest Publications
- Open Access
- 7 March 2017
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 17 (1) , 1-11
Motives and barriers to safer sex and regular STI testing among MSM soon after HIV diagnosis
Understanding why some recently with HIV diagnosed men who have sex with men (MSM) choose for safer sex and regular STI testing, whereas others do not, is important for the development of interventions that aim to improve the sexual health of those newly infected. To gain insight into motives and barriers to condom use and regular STI testing among MSM soon after HIV diagnosis, 30 HIV-positive MSM participated in semi-structured qualitative interviews on sexual health behaviours in the first year after HIV diagnosis. Typical barriers to condom use soon after diagnosis were emotions such as anger, relief, and feelings of vulnerability. Additional barriers were related to pre-diagnosis patterns of sexual-social behaviour that were difficult to change, communication difficulties, and substance use. Barriers to STI testing revolved around perceptions of low STI risk, faulty beliefs, and burdensome testing procedures. The great diversity of motives and barriers to condom use and STI testing creates a challenge to accommodate newly infected men with information, motivation, and communication skills to match their personal needs. An adaptive, tailored intervention can be a promising tool of support.
- 7 March 2017
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 17 (1) , 1-11
Open AccessMotives and barriers to safer sex and regular STI testing among MSM soon after HIV diagnosis
Understanding why some recently with HIV diagnosed men who have sex with men (MSM) choose for safer sex and regular STI testing, whereas others do not, is important for the development of interventions that aim to improve the sexual health of those newly infected. To gain insight into motives and barriers to condom use and regular STI testing among MSM soon after HIV diagnosis, 30 HIV-positive MSM participated in semi-structured qualitative interviews on sexual health behaviours in the first year after HIV diagnosis. Typical barriers to condom use soon after diagnosis were emotions such as anger, relief, and feelings of vulnerability. Additional barriers were related to pre-diagnosis patterns of sexual-social behaviour that were difficult to change, communication difficulties, and substance use. Barriers to STI testing revolved around perceptions of low STI risk, faulty beliefs, and burdensome testing procedures. The great diversity of motives and barriers to condom use and STI testing creates a challenge to accommodate newly infected men with information, motivation, and communication skills to match their personal needs. An adaptive, tailored intervention can be a promising tool of support.
- Open Access
- 22 January 2014
- Published by Springer Nature in BMC Public Health
- Vol. 14 (1) , 66
Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review
Effective screening programs are urgently needed to provide undiagnosed hepatitis C virus (HCV)-infected individuals with therapy. This systematic review of characteristics and outcomes of screening programs for HCV focuses on strategies to identify HCV risk groups hidden in the general population. We conducted a comprehensive search of MEDLINE and EMBASE databases for articles published between 1991–2010, including studies that screened the general population using either a newly developed (nonintegrated) screening program or one integrated in existing health care facilities. Look-back studies, prevalence studies, and programs targeting high-risk groups in care (e.g., current drug users) were excluded. After reviewing 7052 studies, we identified 67 screening programs: 24 nonintegrated; 41 programs integrated in a variety of health care facilities (e.g., general practitioner); and 2 programs with both integrated and nonintegrated strategies. Together, these programs identified approximately 25,700 HCV-infected individuals. In general, higher HCV prevalence was found in programs in countries with intermediate to high HCV prevalence, in psychiatric clinics, and in programs that used a prescreening selection based on HCV risk factors. Only 6 programs used a comparison group for evaluation purposes, and 1 program used theory about effective promotion for screening. Comparison of the programs and their effectiveness was hampered by lack of reported data on program characteristics, clinical follow-up, and type of diagnostic test. A prescreening selection based on risk factors can increase the efficiency of screening in low-prevalence populations, and we need programs with comparison groups to evaluate effectiveness. Also, program characteristics such as type of diagnostic test, screening uptake, and clinical outcomes should be reported systematically.
- 22 January 2014
- Published by Springer Nature in BMC Public Health
- Vol. 14 (1) , 66
Open AccessOutcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review
Effective screening programs are urgently needed to provide undiagnosed hepatitis C virus (HCV)-infected individuals with therapy. This systematic review of characteristics and outcomes of screening programs for HCV focuses on strategies to identify HCV risk groups hidden in the general population. We conducted a comprehensive search of MEDLINE and EMBASE databases for articles published between 1991–2010, including studies that screened the general population using either a newly developed (nonintegrated) screening program or one integrated in existing health care facilities. Look-back studies, prevalence studies, and programs targeting high-risk groups in care (e.g., current drug users) were excluded. After reviewing 7052 studies, we identified 67 screening programs: 24 nonintegrated; 41 programs integrated in a variety of health care facilities (e.g., general practitioner); and 2 programs with both integrated and nonintegrated strategies. Together, these programs identified approximately 25,700 HCV-infected individuals. In general, higher HCV prevalence was found in programs in countries with intermediate to high HCV prevalence, in psychiatric clinics, and in programs that used a prescreening selection based on HCV risk factors. Only 6 programs used a comparison group for evaluation purposes, and 1 program used theory about effective promotion for screening. Comparison of the programs and their effectiveness was hampered by lack of reported data on program characteristics, clinical follow-up, and type of diagnostic test. A prescreening selection based on risk factors can increase the efficiency of screening in low-prevalence populations, and we need programs with comparison groups to evaluate effectiveness. Also, program characteristics such as type of diagnostic test, screening uptake, and clinical outcomes should be reported systematically.
- 1 February 2013
- Published by Wiley in Liver International
- Vol. 33 (5) , 727-738
Screening for hepatitis B and C in first‐generation Egyptian migrants living in the Netherlands
Background Egypt has high prevalence of hepatitis C virus (HCV) infection and intermediate prevalence of hepatitis B virus (HBV) infection; however, infection prevalence among Egyptian migrants is unknown. Considering the asymptomatic onset and development of disease in chronically‐infected patients, many may remain undiagnosed. Aims To evaluate an HCV‐ and HBV‐screening programme designed to identify undetected infections among first‐generation Egyptian migrants in Amsterdam, the Netherlands. Methods In 2009 and 2010, viral hepatitis educational and screening sessions were established at Egyptian meeting places. Data regarding demographics and HCV risk factors were collected. Chronically infected participants were referred and followed up. Phylogenetic analyses were used to ascertain the geographic origin of infections. Results Eleven of 465 (2.4%; 95% CI = 1.3–4.2%) migrants had HCV antibodies; 10/11 were HCV RNA positive. All had genotype 4a, and strains were typical of those of Egypt and the Middle East. Older age and exposure to parenteral antischistosomal therapy (PAT) were significantly associated with HCV. Anti‐HBc prevalence was 16.8% (95% CI = 13.7–20.4%); HBsAg prevalence was 1.1% (95% CI = 0.5–2.5%). All had genotype D, typical of those of the Middle East. Most (9/10 HCV; 3/5 HBV) chronic infections were newly diagnosed; four of the HCV‐infected individuals started treatment. Conclusions Anti‐HCV and HBsAg prevalence among Egyptian migrants was lower compared with the general Egyptian population, but higher than the general population of Western countries. Phylogenetic analyses suggest that all infections were from the region of origin. HCV‐screening programmes should target first‐generation Egyptian migrants, especially those of older age and those who received PAT.
- 1 February 2013
- Published by Wiley in Liver International
- Vol. 33 (5) , 727-738
Screening for hepatitis B and C in first‐generation Egyptian migrants living in the Netherlands
Background Egypt has high prevalence of hepatitis C virus (HCV) infection and intermediate prevalence of hepatitis B virus (HBV) infection; however, infection prevalence among Egyptian migrants is unknown. Considering the asymptomatic onset and development of disease in chronically‐infected patients, many may remain undiagnosed. Aims To evaluate an HCV‐ and HBV‐screening programme designed to identify undetected infections among first‐generation Egyptian migrants in Amsterdam, the Netherlands. Methods In 2009 and 2010, viral hepatitis educational and screening sessions were established at Egyptian meeting places. Data regarding demographics and HCV risk factors were collected. Chronically infected participants were referred and followed up. Phylogenetic analyses were used to ascertain the geographic origin of infections. Results Eleven of 465 (2.4%; 95% CI = 1.3–4.2%) migrants had HCV antibodies; 10/11 were HCV RNA positive. All had genotype 4a, and strains were typical of those of Egypt and the Middle East. Older age and exposure to parenteral antischistosomal therapy (PAT) were significantly associated with HCV. Anti‐HBc prevalence was 16.8% (95% CI = 13.7–20.4%); HBsAg prevalence was 1.1% (95% CI = 0.5–2.5%). All had genotype D, typical of those of the Middle East. Most (9/10 HCV; 3/5 HBV) chronic infections were newly diagnosed; four of the HCV‐infected individuals started treatment. Conclusions Anti‐HCV and HBsAg prevalence among Egyptian migrants was lower compared with the general Egyptian population, but higher than the general population of Western countries. Phylogenetic analyses suggest that all infections were from the region of origin. HCV‐screening programmes should target first‐generation Egyptian migrants, especially those of older age and those who received PAT.
- Open Access
- 10 May 2011
- Published by Springer Nature in BMC Public Health
- Vol. 11 (1) , 293
Reasons for compliance or noncompliance with advice to test for hepatitis C via an internet-mediated blood screening service: a qualitative study
Hepatitis C virus (HCV) is mainly transmitted by exposure to infected blood, and can lead to liver cirrhosis and liver cancer. Since the onset of HCV and the development of liver cirrhosis usually are asymptomatic, many HCV-infected individuals are still undiagnosed. To identify individuals infected with HCV in the general population, a low threshold, internet-mediated blood testing service was set up. We performed a qualitative study examining reasons for compliance and noncompliance with advice to test for HCV via the online blood testing service. Semistructured telephone interviews were conducted with 33 website visitors who had been advised to test for HCV (18 testers, 15 non-testers). Transcribed interviews were analyzed qualitatively and interpreted using psychosocial theories of health behavior. Reasons for testing pertaining to the online service were: the testing procedure is autonomous, personalized test advice is provided online, reminder emails are sent, and there is an online planning tool. Reasons for testing not specific to the online service were: knowing one's status can prevent liver disease and further transmission of HCV, HCV is curable, testing can provide reassurance, physical complaints are present, and there is liver disease in one's social environment. Service-related reasons for not testing pertained to inconvenient testing facilities, a lack of commitment due to the low threshold character of the service, computer/printing problems, and incorrectly interpreting an online planning tool. The reasons for not testing that are not specific to the online service were: the belief that personal risk is low, the absence of symptoms, low perceived urgency for testing and treatment, fear of the consequences of a positive test result, avoiding threatening information, and a discouraging social environment. Features specific to the online service played a significant role in motivation to test for HCV above and beyond the more conventional perceived health benefits of HCV testing. However, some online specific features were considered problematic and need to be adapted. Methods and strategies for dealing with these impeding factors and for improving compliance with testing via the online service are outlined.
- 10 May 2011
- Published by Springer Nature in BMC Public Health
- Vol. 11 (1) , 293
Open AccessReasons for compliance or noncompliance with advice to test for hepatitis C via an internet-mediated blood screening service: a qualitative study
Hepatitis C virus (HCV) is mainly transmitted by exposure to infected blood, and can lead to liver cirrhosis and liver cancer. Since the onset of HCV and the development of liver cirrhosis usually are asymptomatic, many HCV-infected individuals are still undiagnosed. To identify individuals infected with HCV in the general population, a low threshold, internet-mediated blood testing service was set up. We performed a qualitative study examining reasons for compliance and noncompliance with advice to test for HCV via the online blood testing service. Semistructured telephone interviews were conducted with 33 website visitors who had been advised to test for HCV (18 testers, 15 non-testers). Transcribed interviews were analyzed qualitatively and interpreted using psychosocial theories of health behavior. Reasons for testing pertaining to the online service were: the testing procedure is autonomous, personalized test advice is provided online, reminder emails are sent, and there is an online planning tool. Reasons for testing not specific to the online service were: knowing one's status can prevent liver disease and further transmission of HCV, HCV is curable, testing can provide reassurance, physical complaints are present, and there is liver disease in one's social environment. Service-related reasons for not testing pertained to inconvenient testing facilities, a lack of commitment due to the low threshold character of the service, computer/printing problems, and incorrectly interpreting an online planning tool. The reasons for not testing that are not specific to the online service were: the belief that personal risk is low, the absence of symptoms, low perceived urgency for testing and treatment, fear of the consequences of a positive test result, avoiding threatening information, and a discouraging social environment. Features specific to the online service played a significant role in motivation to test for HCV above and beyond the more conventional perceived health benefits of HCV testing. However, some online specific features were considered problematic and need to be adapted. Methods and strategies for dealing with these impeding factors and for improving compliance with testing via the online service are outlined.
- 31 March 2011
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 40 (3) , 345-352
Using Mass Media and the Internet As Tools to Diagnose Hepatitis C Infections in the General Population
- 31 March 2011
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 40 (3) , 345-352
Using Mass Media and the Internet As Tools to Diagnose Hepatitis C Infections in the General Population
- Open Access
- 15 April 2010
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 15 (15) , 19539
Evaluation of a risk assessment questionnaire to assist hepatitis C screening in the general population
Binary file ES_Abstracts_Final_ECDC.txt matches
- 15 April 2010
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 15 (15) , 19539
Open AccessEvaluation of a risk assessment questionnaire to assist hepatitis C screening in the general population
Binary file ES_Abstracts_Final_ECDC.txt matches
- 3 November 2009
- Published by Springer Nature
- p. 333-356
Blood Borne and Sexual Transmission: Hepatitis B and C
- 3 November 2009
- Published by Springer Nature
- p. 333-356
Blood Borne and Sexual Transmission: Hepatitis B and C